Literature DB >> 10813845

Production of transgenic porcine blastocysts by nuclear transfer.

B Kühholzer1, T Tao, Z Machaty, R J Hawley, J L Greenstein, B N Day, R S Prather.   

Abstract

In this study the in vitro development of porcine nuclear transfer (NT) embryos was investigated. Transgenic fetal fibroblast cells that were frozen after 5 days of serum starvation were injected immediately after thawing into enucleated metaphase II (MII) oocytes. Reconstructed embryos were activated by incubation in 200 microM thimerosal followed by a 30-min treatment of 8 mM DTT. The embryos were subsequently cultured in NCSU23, supplemented with 4 mg/ml BSA for 7 days. The actual cleavage rate (embryos showing > or =2 nuclei) in 6 replicates was 33% (ranging from 15% to 50%). Three blastocysts with cell numbers of 14, 15, and 18 were obtained. The blastocyst rate was significantly lower for NT embryos as opposed to parthenogenetically activated embryos (1% vs. 5%; P<0.05). The neomycin-resistance gene was amplified by PCR in all three NT embryos, indicating their origin from the injected transgenic fibroblasts. Efforts are now being directed in improvements in the nuclear transfer technology, whereby viable fetuses or offspring can be produced from these NT-embryos. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10813845     DOI: 10.1002/(SICI)1098-2795(200006)56:2<145::AID-MRD4>3.0.CO;2-8

Source DB:  PubMed          Journal:  Mol Reprod Dev        ISSN: 1040-452X            Impact factor:   2.609


  2 in total

1.  Development and calcium level changes in pre-implantation porcine nuclear transfer embryos activated with 6-DMAP after fusion.

Authors:  Gi-Sun Im; Melissa Samuel; Liangxue Lai; Yanhong Hao; Randall S Prather
Journal:  Mol Reprod Dev       Date:  2007-09       Impact factor: 2.609

2.  Development of porcine embryos reconstituted with somatic cells and enucleated metaphase I and II oocytes matured in a protein-free medium.

Authors:  K Miyoshi; S J Rzucidlo; J R Gibbons; S Arat; S L Stice
Journal:  BMC Dev Biol       Date:  2001-07-11       Impact factor: 1.978

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.